{"nctId":"NCT01174160","briefTitle":"A Study of the Efficacy and Safety of Vernakalant Hydrochloride (MK-6621) in Patients With Atrial Fibrillation (MK-6621-010 AM4)","startDateStruct":{"date":"2010-08"},"conditions":["Atrial Fibrillation"],"count":123,"armGroups":[{"label":"vernakalant HCl","type":"EXPERIMENTAL","interventionNames":["Drug: vernakalant hydrochloride"]},{"label":"placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo to vernakalent hydrochloride"]}],"interventions":[{"name":"vernakalant hydrochloride","otherNames":["MK-6621"]},{"name":"Placebo to vernakalent hydrochloride","otherNames":["Saline"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Abstinent or willing to use 2 acceptable methods of birth control\n* Patient has an atrial arrhythmia with dysrhythmic symptoms\n* Patient is receiving adequate anticoagulant therapy\n* Patient has stable blood pressure\n* Patient weighs between 45 and 136 kg (99 and 300 lbs)\n* Patient is adequately hydrated\n\nExclusion Criteria:\n\n* Patient is pregnant, breast-feeding, or expecting to become pregnant during the study\n* Patient routinely consumes more than 2 alcoholic drinks per day\n* Patient has known or suspected prolonged QT, familial long QT syndrome, previous Torsades de Pointes, Brugada syndrome\n* Patient has known bradycardia, advanced AV block, or sick-sinus syndrome, unless controlled by a pacemaker\n* Patient has severe aortic stenosis\n* Patient has atrial flutter\n* Patient has Class IV congestive heart failure (CHF)\n* Patient has had a myocardial infarction (MI) or acute coronary syndrome (ACS)\n* Patient has had cardiac surgery within 30 days\n* Patient has known atrial thrombus\n* Patient has reversible causes of Atrial Fibrillation\n* Patient has failed electrical cardioversion during current episode of Atrial Fibrillation\n* Patient has uncorrected electrolyte imbalance\n* Patient has clinical evidence of digoxin toxicity\n* Patient has received certain antiarrhythmic drugs or intravenous amiodarone within 7 days\n* Patient is known to be HIV positive\n* Patient has a history of cancer within the past 5 years, except for certain skin or cervical cancers","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Proportion of Patients With Treatment-induced Conversion of Atrial Fibrillation to Sinus Rhythm","description":"The proportion of patients with treatment-induced conversion of atrial fibrillation to sinus rhythm for a minimum duration of 1 minute","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":6,"n":55},"commonTop":["Bradycardia","Ventricular tachycardia","Sneezing","Hypokalaemia","Dizziness"]}}}